Observational studyJournal of bone and mineral metabolism2017

The effects of switching daily teriparatide to oral bisphosphonates or denosumab in patients with primary osteoporosis.

Kosuke Ebina et al.PubMed ↗Publisher ↗

No numbers read from the abstract.